DRUG Bright Minds Biosciences Inc.

20.22USD28.92 CAD · CNQ0.00%Mkt Cap: 199.42M USDP/E: —

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which ar…

Insiders, last 90 days3 buys
Institutional holders20 on file

Key Statistics

Company
Market Cap199.42M USD
Enterprise Value-15.72M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.55M USD
Revenue/Share—
Last Price20.22 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees26
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA10919W4056
Valuation
P/E (Trailing)—
P/E (Forward)-3.79
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.93
EPS (TTM)-1.99 USD
EPS (Forward)-5.34 USD
52W Range
18.142% of range118.84
52W High118.84 USD
52W Low18.14 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-14.91%
ROA-14.49%
ROIC—
ROCE-16.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.08M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-6.58%
Net Debt-215.14M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio121.97
Quick Ratio121.44
Book Value/Sh21.81 USD
Cash/Share21.82 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJul 14, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.86M
Float7.39M
Insiders11.49%
Institutions91.63%
Short Interest
Short Ratio4.2d
Short % Float0.04%
Short % Out.0.03%
Shares Short2.85K
Short (prev mo.)2.76K
Technical
SMA 5045.78 (-55.8%)
SMA 20067.28 (-70.0%)
Beta0.20
S&P 52W Chg12.00%
Avg Vol (30d)1.37K
Avg Vol (10d)2.65K
Technical Indicators
RSI (14)25.3
MACD-12.8372
MACD Signal-12.1276
MACD Hist.-0.7096
BB Upper66.08 USD
BB Middle34.23 USD
BB Lower2.377 USD
BB Width186.11%
ATR (14)2.934 USD
Vol Ratio (20d)0.00x

About Bright Minds Biosciences (CNSX: DRUG)

›

Bright Minds Biosciences (CNSX: DRUG) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 26 employees.

The shares were at 28.92 CAD on 18 November 2026, down 61.4% over 52 weeks. Its 52-week range is 25.95 CAD to 170.00 CAD: the price is 83.0% below the high and 11.4% above the low.

Its market capitalisation is 285.27M CAD.

Bright Minds Biosciences reports return on equity of -14.9% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 307.76M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 22 December 2026.